Research Article
Severity and Determinants of Anemia in TB/HIV Coinfected Adults at Mekelle, Ethiopia: Hospital Based Retrospective Study
Table 2
Baseline clinical characteristics of TB/HIV coinfected patients initiated ART in two public hospitals of Mekelle, Ethiopia, 2009–2016 (n = 305).
| | Baseline clinical characteristics | Severity of anemia | Prevalence rate (number of anemia cases per 100 TB/HIV coinfected adults) | value | | Nonanemia n (%) | Mild anemia n (%) | Moderate anemia n (%) | Severe anemia n (%) |
| | Functional status | | Working | 76 (53.9) | 33 (23.4) | 28 (19.9) | 4 (2.8) | 46.1 | <0.001 | | Ambulatory | 34 (30.9) | 30 (27.3) | 39 (35.50) | 7 (6.4) | 69.1 | | Bedridden | 15 (27.8) | 12 (22.2) | 19 (35.2) | 8 (14.8) | 72.2 |
| | BMI in kg/m2 (median and IQR) | 17.4 (15.6–19.3) | <0.001 |
| | WHO clinical stage | | I/II | 23 (71.9) | 6 (18.7) | 3 (9.4) | 0 (0.0) | 28.1 | <0.001 | | III | 56 (42.7) | 31 (23.7) | 38 (29.0) | 6 (4.6) | 57.3 | | IV | 46 (32.4) | 38 (26.8) | 45 (31.7) | 13 (9.2) | 67.6 |
| | CD4+ cell count (in cells/mm3) | | ≤200 | 90 (36.0) | 64 (25.6) | 79 (31.6) | 17 (6.8) | 64.0 | <0.001 | | >200 | 35 (63.6) | 11 (20.0) | 7 (12.73) | 2 (3.64) | 36.4 |
| | Serum ALT in IU/l (median and IQR) | 34.5 (24–51) | 0.871 |
| | Serum AST in IU/l (median and IQR) | 40 (28–60) | 0.122 |
|
|
ALT: alanine transferase, AST: aspartate transferase, BMI: body mass index.
|
